Related Experiment Video

Updated: May 1, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

974

Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma

Maria M Caffarel1, Nicholas Coleman

  • 1Department of Pathology, University of Cambridge, UK.

The Journal of Pathology
|March 25, 2014
PubMed

Insights

Oncostatin M receptor (OSMR) is overexpressed in cervical squamous cell carcinoma (SCC), driving cancer growth and poor outcomes. Targeting OSMR offers a promising new treatment strategy for advanced cervical cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Cervical carcinoma is a leading cause of cancer deaths in women globally.
  • Current treatments for advanced cervical cancer have limited efficacy, with low survival rates.
  • The oncostatin M receptor (OSMR) is a novel molecular target identified in cervical squamous cell carcinoma (SCC).

Purpose of the Study:

  • To investigate the role of OSMR in the development and progression of cervical SCC.
  • To evaluate OSMR as a potential therapeutic target for cervical cancer treatment.

Main Methods:

  • Analysis of OSMR copy number gain and overexpression in advanced cervical SCC.
  • Assessment of OSMR ligand (OSM) interactions and downstream effects on cancer cells.
  • Exploration of antibody-mediated inhibition of OSMR as a therapeutic strategy.

Main Results:

  • OSMR is frequently copy number gained and overexpressed in advanced cervical SCC.
  • OSMR overexpression correlates with significantly worse clinical outcomes.
  • OSM-induced OSMR signaling promotes angiogenesis, migration, and invasiveness in cervical SCC cells.

Conclusions:

  • OSMR is a key driver of malignant progression in cervical SCC.
  • Targeting OSMR, particularly through antibody-mediated inhibition, represents a promising therapeutic avenue for advanced cervical cancer and potentially other SCCs.
Keywords:
5p gainangiogenesiscell migrationcervixinvasiononcostatin M receptorsquamous cell carcinoma

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.4K
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

13.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K